Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E; Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group. Bird J, et al. Among authors: soutar r. Br J Haematol. 2009 Oct;147(1):22-42. doi: 10.1111/j.1365-2141.2009.07807.x. Epub 2009 Aug 10. Br J Haematol. 2009. PMID: 19673884 Free article. No abstract available.
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.
Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, Samson D; Guidelines Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Soutar R, et al. Br J Haematol. 2004 Mar;124(6):717-26. doi: 10.1111/j.1365-2141.2004.04834.x. Br J Haematol. 2004. PMID: 15009059 Free article. No abstract available.
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.
Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, Samson D; Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Soutar R, et al. Clin Oncol (R Coll Radiol). 2004 Sep;16(6):405-13. doi: 10.1016/j.clon.2004.02.007. Clin Oncol (R Coll Radiol). 2004. PMID: 15487132 No abstract available.
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
Burnett AK, Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K; United Kingdom National Cancer Research Institute Haematological Oncology Study Group. Burnett AK, et al. Br J Haematol. 2009 May;145(3):318-32. doi: 10.1111/j.1365-2141.2009.07604.x. Epub 2009 Mar 8. Br J Haematol. 2009. PMID: 19291085 Free article. Clinical Trial.
Advances in the management of myeloma.
Hughes M, Soutar RL. Hughes M, et al. Among authors: soutar rl. Scott Med J. 2005 May;50(2):47-50. doi: 10.1177/003693300505000201. Scott Med J. 2005. PMID: 15977512 Review. No abstract available.
Multiple Pappenheimer bodies.
Fyfe AJ, Soutar RL. Fyfe AJ, et al. Br J Haematol. 2005 Sep;130(5):651. doi: 10.1111/j.1365-2141.2005.05547.x. Br J Haematol. 2005. PMID: 16115118 Free article. No abstract available.
85 results